A RING E3-substrate complex poised for ubiquitin-like protein transfer: structural insights into cullin-RING ligases - PubMed (original) (raw)

A RING E3-substrate complex poised for ubiquitin-like protein transfer: structural insights into cullin-RING ligases

Matthew F Calabrese et al. Nat Struct Mol Biol. 2011.

Abstract

How RING E3 ligases mediate E2-to-substrate ubiquitin-like protein (UBL) transfer remains unknown. Here we address how the RING E3 RBX1 positions NEDD8's E2 (UBC12) and substrate (CUL1). We find that existing structures are incompatible with CUL1 NEDD8ylation and report a new conformation of RBX1 that places UBC12 adjacent to CUL1. We propose RING domain rotation as a general mechanism for UBL transfer for the largest family of E3s.

PubMed Disclaimer

Figures

Figure 1

Figure 1

UBC12–RBX1 interactions. (a) WT and mutant UBC12-mediated CUL1 NEDD8ylation in vitro. Mutated residues are orange on UBC12 (otherwise cyan)–RBX1 (pink) model. (b) 2D HSQC [15N-1H] spectra of 15N-UBC12core in the absence (red) and presence (blue) of equimolar RBX1RING. A subset of shifted resonances are labeled in the spectra. Residues with chemical shift differences greater than one standard deviation above the mean are labeled and colored orange on UBC12 (otherwise cyan)–RBX1 (pink) model.

Figure 2

Figure 2

Models from prior structures reveal an E2-to-substrate gap. (a) Structural model of CUL1CTD–RBX1–UBC12core (colored light green, pink, cyan respectively) complex based on previous CUL1–RBX1 and RING–E2 structures–,, (Supplementary Fig. 1). CUL1 NEDD8 modification site and UBC12 catalytic cysteine are indicated by blue and yellow spheres respectively. (b) In vitro CUL1 NEDD8ylation assays using disulfide-linked (S~S) and unlinked (SH SH) split’n’coexpress CUL1–RBX1 (ref. 7). Pairs A–C refer to three distinct combinations of engineered cysteines (Supplementary Fig. 2).

Figure 3

Figure 3

Structure of CUL1CTD–RBX1 in new conformation. (a) One copy of CUL1CTD (dark green) –RBX1 (purple) from the asymmetric unit. (b) Same as (a), but rotated ~70° in y and ~20° in x. (c) Structural overlay with previous CUL1CTD (light green) oriented similarly to (a),. (d) Structural overlay with previous RBX1 (pink) in same orientation as (b). (e) Structural model of CUL1CTD–RBX1–UBC12core (light green, purple, cyan respectively) complex based on the new RBX1 conformation. (f) Bis-Maleimidoethane (BMOE)-crosslinking between engineered cysteine mutants of Ubc12 and CUL1CTD. Residues mutated to cysteine are numbered on the model (left, view rotated by ~70° and ~40° about the×and z-axes relative to panel e) and products of crosslinking reactions are shown for all possible Ubc12+CUL1–RBX1 combinations (right). Note residue numbering for yeast Ubc12. For reference, Ubc12 catalytic cysteine and CUL1 NEDD8ylation site are shown as sticks. (g) In vitro CUL1 NEDD8ylation for UBC12 mutants at the predicted interface. Mutated residues are shown on the model (left).

Comment in

Similar articles

Cited by

References

    1. Deshaies RJ, Joazeiro CA. Annu Rev Biochem. 2009;78:399–434. - PubMed
    1. Zheng N, Wang P, Jeffrey PD, Pavletich NP. Cell. 2000;102:533–539. - PubMed
    1. Mace PD, et al. J Biol Chem. 2008;283:31633–31640. - PubMed
    1. Yin Q, et al. Nat Struct Mol Biol. 2009;16:658–666. - PMC - PubMed
    1. Zimmerman ES, Schulman BA, Zheng N. Curr Opin Struct Biol. 2010;20:714–721. - PMC - PubMed

Publication types

MeSH terms

Substances

Grants and funding

LinkOut - more resources